Brian P. McKeon - 16 Feb 2022 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role
Executive VP & CFO
Signature
/s/ Lily J. Lu, Attorney-in-Fact for Brian P. McKeon
Issuer symbol
IDXX
Transactions as of
16 Feb 2022
Net transactions value
+$99,970
Form type
4
Filing time
17 Feb 2022, 16:49:37 UTC
Previous filing
16 Feb 2022
Next filing
16 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDXX Common Stock Options Exercise $99,970 +706 +2.6% $141.60 28,154 16 Feb 2022 Direct
holding IDXX Common Stock 18,050 16 Feb 2022 by Estony McKeon Family, LLC

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Incentive Stock Option (right-to-buy) Options Exercise -706 -100% 0 16 Feb 2022 Common Stock 706 $141.60 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of option to buy 706 shares of IDEXX Laboratories, Inc. common stock that vested in one installment on February 14, 2022.
F2 Not applicable.